Preclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotype

Preclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotype

Item
http://www.wikidata.org/entity/Q27021772
Nicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signalsThe role of the habenula in drug addiction.Significant associations of CHRNA2 and CHRNA6 with nicotine dependence in European American and African American populationsComparison of effects produced by nicotine and the α4β2-selective agonist 5-I-A-85380 on intracranial self-stimulation in rats.Acute ethanol inhibits dopamine release in the nucleus accumbens via α6 nicotinic acetylcholine receptorsNicotinic receptor antagonists as treatments for nicotine abuse.Effects of nicotinic acetylcholine receptor agonists in assays of acute pain-stimulated and pain-depressed behaviors in rats.Potential therapeutic uses of mecamylamine and its stereoisomers.Ventral tegmental area α6β2 nicotinic acetylcholine receptors modulate phasic dopamine release in the nucleus accumbens core.Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration.The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptorsLong-term nicotine treatment down-regulates α6β2* nicotinic receptor expression and function in nucleus accumbens.Effect of neuronal nicotinic acetylcholine receptor genes (CHRN) on longitudinal cigarettes per day in adolescents and young adults.Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.Varenicline enhances dopamine release facilitation more than nicotine after long-term nicotine treatment and withdrawal.α6β2*-subtype nicotinic acetylcholine receptors are more sensitive than α4β2*-subtype receptors to regulation by chronic nicotine administration.Deletion of lynx1 reduces the function of α6* nicotinic receptors.
P2860

Preclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotype

Item
http://www.wikidata.org/entity/Q27021772
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Preclinical evidence that acti ...... s nicotine addiction phenotype
@ast
Preclinical evidence that acti ...... s nicotine addiction phenotype
@en
Preclinical evidence that acti ...... s nicotine addiction phenotype
@nl
type
label
Preclinical evidence that acti ...... s nicotine addiction phenotype
@ast
Preclinical evidence that acti ...... s nicotine addiction phenotype
@en
Preclinical evidence that acti ...... s nicotine addiction phenotype
@nl
prefLabel
Preclinical evidence that acti ...... s nicotine addiction phenotype
@ast
Preclinical evidence that acti ...... s nicotine addiction phenotype
@en
Preclinical evidence that acti ...... s nicotine addiction phenotype
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Preclinical evidence that acti ...... s nicotine addiction phenotype
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932